Recent Posts
Archives
Race Oncology speaks to Proactive Investor as part of the ASX Small and Mid-Cap Conference
![ProactiveattheASXSmallandMidCapConference](https://www.irdepartment.com.au/site/irmblogpropertyfile/342/ProactiveattheASXSmallandMidCapConference.png)
Race Oncology (ASX:RAC) CEO Phil Lynch provides an update on the Company’s activities and new strategy as part of their participation in the ASX Small and Mid-Cap Conference 2022.